Search

everythinglearnresearchcommunity

for

Search:↓

Moderate facial angiofibroma significantly reduces quality of life compared to almost-clear cases, highlighting the benefits of treatment.

Hair cortisol levels don't reliably indicate chronic stress in people with multiple sclerosis.

Some treatments for multiple sclerosis can cause hair loss.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

A high fat lard diet may protect against skin fibrosis and affect hair growth.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

People with Lichen sclerosus are more likely to have skin conditions like vitiligo and alopecia areata, heart disease risks, and other health issues. They should be checked for these, but screening plans shouldn't differ based on gender due to lack of data.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Hair loss from multiple sclerosis treatments is usually temporary.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

PEH in vulvar LS is common and needs careful diagnosis to avoid confusion with cancer.

Effective pain management in multiple sclerosis requires individualized treatment strategies.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Cord blood platelet-rich plasma may safely improve vulvar lichen sclerosus symptoms.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Ocrelizumab may cause total body hair loss in some patients.